Of these, different non-coding TERT variants have been shown to confer variable risks for MPN development, with intron 2 variants having significant association with more aggressive MPN phenotype and intron 3 variants associated with more indolent course of asymptomatic CH [17, 18]. Here, TERT is linked to myeloproliferative neoplasm.